Clinical Trials · NCT03252353
Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly
- Phase
- Phase 3
- Recruitment status
- Unknown
- Sponsor
- Chiasma, Inc.
- Enrollment
- 56
- Start date
- Sep 2017
- Locations
- 60 sites, 17 countries
- Primary endpoint
- Number of Patients Who Maintain Their Biochemical Response at the End of the Double Blind Placebo Controlled (DPC) Period.